We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Source Bio. | LSE:SBS | London | Ordinary Share | GB0009739649 | ORD 2P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 17.50 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMSBS
RNS Number : 8317J
Source BioScience PLC
14 September 2016
14 September 2016
Source BioScience plc
(or "the Company")
PDMR dealings
This announcement is made in accordance with Article 19.3 of MAR and Rule 8 of the City Code on Takeovers and Mergers following the exercise of share options granted under the Company's Share Option Schemes on behalf of PDMRs.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Hot Features
Premium
1 Details of the person discharging managerial responsibilities / person closely associated
--- -------------------------------------------------------------------------------------------------------------
a) Name Mr Laurie Turnbull
--- ------------------------------------------------------------ -----------------------------------------------
b) Position/status PDMR, Chairman
--- ------------------------------------------------------------ -----------------------------------------------
c) Initial notification /Amendment Initial Notification
--- ------------------------------------------------------------ -----------------------------------------------
2 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
--- -------------------------------------------------------------------------------------------------------------
a) Name Source BioScience plc
--- ------------------------------------------------------------ -----------------------------------------------
3 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
--- -------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 2p each ("Ordinary Shares")
Identification code
ISIN Code: GB0009739649
--- ------------------------------------------------------------ -----------------------------------------------
b) Nature of the transaction Exercise of share options
--- ------------------------------------------------------------ -----------------------------------------------
c) Price(s) and volume(s) Price: Nil
Volume: 298,667
--- ------------------------------------------------------------ -----------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
--- ------------------------------------------------------------ -----------------------------------------------
e) Date of the transaction 13 September 2016
--- ------------------------------------------------------------ -----------------------------------------------
f) Place of the transaction Outside a trading venue
--- ------------------------------------------------------------ -----------------------------------------------
4 Resultant holding in Ordinary Shares 3,048,667 (0.8%)
--- ------------------------------------------------------------ -----------------------------------------------
1 Details of the person discharging managerial responsibilities / person closely associated
--- -------------------------------------------------------------------------------------------------------------
a) Name Dr Nick Ash
--- ------------------------------------------------------------ -----------------------------------------------
b) Position/status PDMR, CEO
--- ------------------------------------------------------------ -----------------------------------------------
c) Initial notification /Amendment Initial Notification
--- ------------------------------------------------------------ -----------------------------------------------
2 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
--- -------------------------------------------------------------------------------------------------------------
a) Name Source BioScience plc
--- ------------------------------------------------------------ -----------------------------------------------
3 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
--- -------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 2p each ("Ordinary Shares")
Identification code
ISIN Code: GB0009739649
--- ------------------------------------------------------------ -----------------------------------------------
b) Nature of the transaction Exercise of share options
--- ------------------------------------------------------------ -----------------------------------------------
c) Price(s) and volume(s) Price: Nil
Volume: 3,474,965
--- ------------------------------------------------------------ -----------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
--- ------------------------------------------------------------ -----------------------------------------------
e) Date of the transaction 13 September 2016
--- ------------------------------------------------------------ -----------------------------------------------
f) Place of the transaction Outside a trading venue
--- ------------------------------------------------------------ -----------------------------------------------
4 Resultant holding in Ordinary Shares 3,974,965 (1.1%)
--- ------------------------------------------------------------ -----------------------------------------------
1 Details of the person discharging managerial responsibilities / person closely associated
--- -------------------------------------------------------------------------------------------------------------
a) Name Dr Nick Leaves
--- ------------------------------------------------------------ -----------------------------------------------
b) Position/status PDMR, Chief Operating Officer
--- ------------------------------------------------------------ -----------------------------------------------
c) Initial notification /Amendment Initial Notification
--- ------------------------------------------------------------ -----------------------------------------------
2 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
--- -------------------------------------------------------------------------------------------------------------
a) Name Source BioScience plc
--- ------------------------------------------------------------ -----------------------------------------------
3 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
--- -------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 2p each ("Ordinary Shares")
Identification code
ISIN Code: GB0009739649
--- ------------------------------------------------------------ -----------------------------------------------
b) Nature of the transaction Exercise of share options
--- ------------------------------------------------------------ -----------------------------------------------
c) Price(s) and volume(s) Price: Nil
Volume: 2,867,456
--- ------------------------------------------------------------ -----------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
--- ------------------------------------------------------------ -----------------------------------------------
e) Date of the transaction 13 September 2016
--- ------------------------------------------------------------ -----------------------------------------------
f) Place of the transaction Outside a trading venue
--- ------------------------------------------------------------ -----------------------------------------------
4 Resultant holding in Ordinary Shares 3,896,013 (1.1%)
--- ------------------------------------------------------------ -----------------------------------------------
1 Details of the person discharging managerial responsibilities / person closely associated
--- -------------------------------------------------------------------------------------------------------------
a) Name Mr Tim Metcalfe
--- ------------------------------------------------------------ -----------------------------------------------
b) Position/status PDMR, Group Finance Director
--- ------------------------------------------------------------ -----------------------------------------------
c) Initial notification /Amendment Initial Notification
--- ------------------------------------------------------------ -----------------------------------------------
2 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
--- -------------------------------------------------------------------------------------------------------------
a) Name Source BioScience plc
--- ------------------------------------------------------------ -----------------------------------------------
3 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
--- -------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 2p each ("Ordinary Shares")
Identification code
ISIN Code: GB0009739649
--- ------------------------------------------------------------ -----------------------------------------------
b) Nature of the transaction Exercise of share options
--- ------------------------------------------------------------ -----------------------------------------------
c) Price(s) and volume(s) Price: Nil
Volume: 1,606,154
--- ------------------------------------------------------------ -----------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
--- ------------------------------------------------------------ -----------------------------------------------
e) Date of the transaction 13 September 2016
--- ------------------------------------------------------------ -----------------------------------------------
f) Place of the transaction Outside a trading venue
--- ------------------------------------------------------------ -----------------------------------------------
4 Resultant holding in Ordinary Shares 1,606,154 (0.4%)
--- ------------------------------------------------------------ -----------------------------------------------
Enquiries
Source BioScience plc
Dr Nick Ash, Company Secretary
Tel: +44 (0) 115 973 9010
Email: enquiries@sourcebioscience.com
www.sourcebioscience.com
About Source BioScience:
Source BioScience plc (LSE: SBS) is a trusted provider of state of the art Laboratory Services and Products to the healthcare and clinical, life and applied sciences and biopharma industries. It is an international business operating ten state of the art facilities in five countries and with customers in over 90 countries worldwide. The Group offers a complementary portfolio of Laboratory Services and Products that share common technologies, laboratory processes, infrastructure and expertise. These include Diagnostics, DNA Sequencing and Genomics, Analytical and Regulated Services, Clinical Products, Life Science Research Reagents and Controlled Environment for a comprehensive range of applications. These Laboratory Services and Products are provided to a large and diverse customer base including the top 50 pharmaceutical companies, leading universities and research institutes worldwide, the UK NHS and other healthcare providers. The Group is listed on the Premium Main Market of the London Stock Exchange.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHSFAFSLFMSEEU
(END) Dow Jones Newswires
September 14, 2016 06:29 ET (10:29 GMT)
1 Year Source Bioscience Chart |
1 Month Source Bioscience Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
